KR20070039114A - The use of medicinal plants and extracts thereof for the well-being of animals in veterinary medicine and zootechnics - Google Patents

The use of medicinal plants and extracts thereof for the well-being of animals in veterinary medicine and zootechnics Download PDF

Info

Publication number
KR20070039114A
KR20070039114A KR1020077002506A KR20077002506A KR20070039114A KR 20070039114 A KR20070039114 A KR 20070039114A KR 1020077002506 A KR1020077002506 A KR 1020077002506A KR 20077002506 A KR20077002506 A KR 20077002506A KR 20070039114 A KR20070039114 A KR 20070039114A
Authority
KR
South Korea
Prior art keywords
portulaca
genus
aerial parts
extracts
animals
Prior art date
Application number
KR1020077002506A
Other languages
Korean (ko)
Inventor
안드레아 지오리
쟝파올로 포르니
페데리코 후랑세스치
Original Assignee
인데나 에스피아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 인데나 에스피아 filed Critical 인데나 에스피아
Publication of KR20070039114A publication Critical patent/KR20070039114A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/60Feeding-stuffs specially adapted for particular animals for weanlings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/36Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catching Or Destruction (AREA)
  • Cultivation Receptacles Or Flower-Pots, Or Pots For Seedlings (AREA)

Abstract

본 발명은 가축용 성장 촉진제의 제조를 위한 쇠비름속(Portulaca genus) 식물의 지상부(aerial parts)와 그의 추출물, 특히 쇠비름(Portulaca oleracea)의 용도에 관한 것이다.The present invention relates to the use of aerial parts and extracts thereof, in particular Portulaca oleracea , of the Portulaca genus plant for the production of growth promoters for livestock.

쇠비름속(Portulaca genus), 쇠비름(Portulaca oleracea), 성장 촉진제(growth promoters)Pursula (Portulaca genus), Purslane (Portulaca oleracea), growth promoters

Description

가축병 치료제와 축산에서 동물의 안녕을 위한 약용 식물과 그 추출물의 용도{THE USE OF MEDICINAL PLANTS AND EXTRACTS THEREOF FOR THE WELL-BEING OF ANIMALS IN VETERINARY MEDICINE AND ZOOTECHNICS}USE OF MEDICINAL PLANTS AND EXTRACTS THEREOF FOR THE WELL-BEING OF ANIMALS IN VETERINARY MEDICINE AND ZOOTECHNICS}

본 발명은 가축용 성장 촉진제의 제조를 위한 쇠비름속(Portulaca genus)의 식물, 특히 쇠비름(Portulaca oleracea)의 지상부(aerial parts)의 추출물의 용도에 관한 것이다.The present invention relates to the use of extracts of the plant of the genus Portulaca genus, in particular the aerial parts of the species of purslane ( Portulaca oleracea ), for the production of growth promoters for livestock.

세균성 항생제 저항력은 수의학 분야를 포함하는 공중 위생에 악영향을 주는 점점 증가하는 문제 중 하나이다.Bacterial antibiotic resistance is one of the increasing problems that adversely affect public health, including the veterinary field.

수의학 약제로 항생제의 용도는 인간 약제에 사용된 것과 대개는 같거나 또는 엄밀하게는 연관되어있고, 성장 촉진제(growth promoters)와 대량 후예방제(mass metaphylactic agents)처럼 부수적-치료 복용량(sub-therapeutical doses)으로 항생제를 사용하도록 확립된 습관이 가축과 인간에서 종종 같은 병리학적 원인이 되는 다수의 세균 종(bacterial species)에 의해 획득된 항생물질 내성의 확산의 주된 원인이다. 고기육(meat) 중에 항생물질 잔사의 존재와, 간접적으로, 항 생제-내성균의 선택은 인간에게 병원성 세균의 내성 유전자를 옮길 수 있고, 인간의 건강에 위험할 수 있다.The use of antibiotics in veterinary medicine is usually the same or strictly related to that used in human medicine, and sub-therapeutical doses such as growth promoters and mass metaphylactic agents Habits established to use antibiotics are a major cause of the proliferation of antibiotic resistance obtained by a number of bacterial species that are often the same pathological cause in livestock and humans. The presence of antibiotic residues in meat and, indirectly, the selection of antibiotic-resistant bacteria can carry the pathogenic bacteria's resistance genes to humans and can be dangerous to human health.

전체 항생제 생산량의 약 25 %는 가축에 쓰일 예정이고, 이들 중 90 %는 질병의 예방뿐만 아니라 성장 촉진을 위한 부수적-치료 복용량(sub-therapeutical doses)으로 쓰인다. 항균제(antimicrobials)는 생산 성능의 증대를 위해 50년대 이래로 축산에서 사료에 첨가되고, 광범위하게 사용되어왔다. 돼지 사육에서, 예를 들면, 돼지새끼의 이유는 전이(transfer)에 연관된 고통주는 일과 같이 동물의 다른 그룹의 혼합은 가장 민감한 단계이고, 사료의 변화는 감염을 보다 걸리기 쉽게 만드는, 동물의 장내 미생물상(microbial flora)의 변화(alterntions)를 유발한다. 젖을 떼는 동안 발생한 풍토병의 예방법으로 항생제의 사용은 70 - 80 일된 동물까지 연장될 수 있는 시간 동안의 사료에 포함시키는 항생제의 일반화된 사용으로 이루어진다.About 25% of the total antibiotic production will be for livestock, 90% of which will be used as sub-therapeutical doses to promote growth as well as to prevent disease. Antimicrobials have been added to feed in livestock and have been used extensively since the 50s to increase production performance. In pig breeding, for example, the piglet's reason is that the mixing of different groups of animals, such as pain associated with transfer, is the most sensitive stage, and changes in feed are the intestinal microflora of animals, making them more susceptible to infection. (microbial flora) causes alterations. The use of antibiotics to prevent endemic diseases that occur during weaning consists of the generalized use of antibiotics in feed for a time that can be extended to 70-80 days old animals.

항생제-내성 위급의 결과로, 유럽연합(European Union)은 사료와 물을 통한 성장 촉진제, 항균성 예방법, 복합-치료법, 대량 투약법으로 항생제의 사용에 관여하는 제한된 접근을 따랐다. 특히, 유럽연합(EU)은 2006년까지 성장 촉진제로 항생제의 사용을 관여하는 모든 권한을 철회하는 중이다. 그러나, 성장 촉진제와 예방제로서의 항생제 사용의 금지는 설사(diarrhoea), 체중 감소, 폐사(mortality)의 증가로 동물들 건강의 악화를 수반할 것이다. As a result of the antibiotic-resistant crisis, the European Union has followed a limited approach involving the use of antibiotics as feed and water growth promoters, antimicrobial prophylaxis, multi-treatment, and bulk dosing. In particular, the European Union (EU) is withdrawing all rights to engage in the use of antibiotics as growth promoters by 2006. However, the prohibition of the use of antibiotics as growth promoters and prophylactic agents will entail deterioration of the health of animals with diarrhoea, weight loss, and increased mortality.

다른 접근법들은 항생제의 사용에 대하여, 축산, 보다 상세히는 돼지 사육의 의존성(dependency)을 줄이기 위하여 존재한다 : 하나의 선택은 세균의 통제를 통 하여 작용하고, 동물 본연의 반응성을 개선하는, 그것에 의해 성능의 최적화와 마찬가지로 건강의 개선을 꾀하는, 대안의 개발이다. 그러한 대안 해법을 위한 강제적 특징(mandatory characteristics)은 생산자에게는 사용이 안전하고 가격이 싸며, 그러므로 소비자에게 유리하다.Other approaches exist for the use of antibiotics to reduce the dependence of animal husbandry, and more particularly pig breeding: one option is to act through bacterial control, thereby improving the intrinsic responsiveness of animals. As with the optimization of performance, the development of alternatives aimed at improving health. The mandatory characteristics for such an alternative solution are safe to use for producers and inexpensive, and therefore advantageous to the consumer.

쇠비름속(Portulaca)은 모든 온도와 온난한 지역에 존재하는 일년생 초본 식물이다.Purslane ( Portulaca ) is an annual herbaceous plant that exists in all temperatures and warm areas.

쇠비름속(Portulaca genus) 식물의 지상부(aerial parts)는. 다양한 원인(치질(hemorrhoids), 자궁(uterus))의 출혈을 억제하고, 미란(sores), 습진(eczema), 뱀 또는 벌레 물림을 치료하는 중국 전통 약제로, 수성 또는 물-에탄올(water-ethanol) 추출물의 형태로, 오랜 세월동안 사용되어 왔다.The aerial parts of the Portulaca genus plant are: Traditional Chinese medicine that inhibits bleeding of various causes (hemorrhoids, uterus), and cures erosions, eczema, snakes, or insect bites, or aqueous or water-ethanol ) Has been used for many years in the form of extracts.

쇠비름속(Portulaca genus) 식물, 특히 쇠비름(Portulaca oleracea)의 식물 부분, 특히 빻은 지상부(ground aerial parts) 또는 지상부(aerial parts)의 추출물의 투여는 가축에게 성장-촉진 항생제의 투여와 최소한 동량의 활성이라는 것이 비로서 밝혀졌다.Administration of Portulaca genus plants, in particular plant parts of Portulaca oleracea , in particular ground aerial parts or aerial parts, can be applied to livestock with at least the same amount of activity as growth-promoting antibiotics. It turned out to be rain.

따라서, 본 발명은 적합한 담체 또는 사료 보충물의 형태에 혼합된 쇠비름속(Portulaca), 특히 쇠비름(Portulaca oleracea)의 지면 지상부 또는 지상부의 추출물을 활성성분으로 구성된 수의 또는 축산 용도의 조성물에 관한 것이다.Accordingly, the present invention relates to a composition of a suitable carrier or feed of Portulaca oleracea in (Portulaca), in particular Portulaca oleracea ground aerial parts or the number consisting of the extract of the aerial parts with the active ingredient or livestock use of (Portulaca oleracea) mixture to supplement the form of water.

언급된 조성물은 성장-촉진 항생제의 결점과 부작용의 유발 없이, 가축에서, 특히 돼지(swine), 소(bovine), 양(ovine), 말(equine), 좀더 바람직하게는 돼지의 성장을 촉진하는데 유효함이 입증되었다.The mentioned compositions promote the growth of livestock, in particular swine, bovine, ovine, equine, more preferably pigs, without causing the drawbacks and side effects of growth-promoting antibiotics. It proved valid.

복용량은 동물의 종(species), 크기(size), 무게(weight), 나이(age)와 같은 다수의 요인들에 좌우될 것이다. 원칙적으로, 전형적인 복용량은 동물/일 당 0.1 - 10 g의 추출물/지상부 범위일 것이다.Dosage will depend on a number of factors such as the species, size, weight and age of the animal. In principle, typical dosages will range from 0.1-10 g of extract / floor per animal / day.

본 발명에 따른 사용 가능한 추출물은 바람직하게는 실온에서, 용매로 쇠비름(Portulaca oleracea)의 지상부의 반복된 추출로 구성된 공정에 의해 제조될 수 있다. 용매는 바람직하게는 하이드로-알코올성 에탄올(hydro-alcoholic ethanol)/물(water) 1 : 1 혼합물로 구성된 추출법을 사용했다. 얻어진 추출물을 모으고 감압 하에서 농축시킨다.The extracts usable according to the invention can be prepared by a process consisting of repeated extraction of the ground portion of Purslane ( Portulaca oleracea ) with a solvent, preferably at room temperature. The solvent was preferably used an extraction method consisting of a hydro-alcoholic ethanol / water 1: 1 mixture. The obtained extracts are combined and concentrated under reduced pressure.

다음 실시예는 본 발명을 상세히 설명하고자 하는 것이다.The following examples are intended to illustrate the invention in detail.

실시예Example 1 : 축산용의 쇠비름( 1: Purslane for livestock Portulaca Portulaca oleraceaoleracea ) 지상부(aerial parts) 추출물Aerial parts extract

추출물의 제조Preparation of Extract

쇠비름(Portulaca oleracea)의 건조시켜 빻은 지상부 1000 g을 추출기(percolator)에 넣었다. 재료는 혼합물 에탄올(ethanol)/물 혼합물 1 : 1 v/v로 덮어두고, 3시간 동안 실온(RT)에서 방치하였다. 다음 용매는 침출시키고, 재료는 에탄올(ethanol)/물 혼합물 1 : 1 v/v의 추가량으로 덮었다. 절차는 약 7700 ml의 용매 총량을 사용하여 6 차례 반복시켰다. 6개의 침출액(percolates)은 여과하고 모은 후 감소된 압력 하에서, 농축시켜, 어두운 흡습성의 갈을 수 있는 고체(241 g : 수득률 24.1 % w/w)가 획득되었다.1000 g of dried ground ground portion of purslane ( Portulaca oleracea ) was placed in a percolator. The material was covered with the mixture ethanol / water mixture 1: 1 v / v and left at room temperature (RT) for 3 hours. The solvent was then leached and the material covered with an additional amount of ethanol / water mixture 1: 1 v / v. The procedure was repeated six times using a total amount of solvent of about 7700 ml. Six percolates were filtered, collected and concentrated under reduced pressure to give a dark, hygroscopic, grindable solid (241 g, yield 24.1% w / w).

실시예Example 2 : 생체 내 실험 2: in vivo experiment

실험은 120 마리의 새끼돼지들을 30 마리씩 각각 4 그룹으로 나누어 수행했다.The experiment was carried out with 120 piglets divided into four groups of 30 animals each.

그룹 1(대조군)은 부가물 없는 표준 사료로 처리했다. 그룹 2(항생제)는 사료 kg 당 2 g의 아프라마이신(apramycin)과 1 g의 콜리스틴(colistin)을 함유한 약을 넣은 사료로 처리했다. 그룹 3은 쇠비름속(Portulaca) 추출물 2 g/kg이 첨가된 표준 사료로 처리했다. 그룹 4는 쇠비름속(Portulaca)의 미세하게 빻은 지상부 5 g/kg이 첨가된 표준 사료로 처리했다.Group 1 (control) was treated with standard feed without additives. Group 2 (antibiotic) was treated with a diet containing a drug containing 2 g of apramycin and 1 g of colistin per kg of feed. Group 3 was treated with standard feed supplemented with 2 g / kg of Portulaca extract. Group 4 was treated with standard feed supplemented with 5 g / kg finely ground ground roots from Portulaca .

모든 동물들은 22일에서 41일에 젖을 떼는 동안 처리했다.All animals were treated during weaning from 22 to 41 days.

동물들의 안녕은 전체 무게 증가, 사료의 매일 섭취량, 설사하는 동물의 백분률에 의해 평가했다. 또한 41일부터 대변 시료(faeces samples)를 전체 중생생물 전하(mesophyte charge), 전체 대장균(coliform)과 락토바실리(Lactobacilli)의 세균의 총수(counts)를 미생물학적으로 분석했다. 모든 요소들(parameters)은 그 분야에 순련된 이들에게 알려진 표준 방법으로 평가했다.Animal well-being was assessed by increasing total weight, daily intake of feed and percentage of diarrhea animals. From day 41, faeces samples were microbiologically analyzed for total mesophyte charge, total coliform and counts of Lactobacilli bacteria. All parameters were evaluated by standard methods known to those skilled in the field.

다음의 표들에 보고된 결과는 미세하게 빻은 지상부뿐만 아니라 물-에탄올(water-ethanol) 추출물의 형태로 쇠비름속(Portulaca)의 표준 사료에 첨가는, 비록 시험관 내에서 그 자체로 항생제 활성은 없지만, 이유식품 중에 항생작용을 갖는 성장 촉진제로 유익한 교체가 될 수 있음이 입증되었다.The results reported in the following tables indicate that addition to standard feed of Portulaca in the form of water-ethanol extracts, as well as finely ground parts, has no antibiotic activity in vitro, although It has been proven that it can be a beneficial replacement for antibiotic growth promoters in weaning foods.

표1. 41일의 새끼돼지 무게와 평균무게 증가량(MWI, Mean Weight Increase).Table 1. Pig weight and mean weight increase (MWI) for 41 days.

처리 process 새끼돼지 무게(kg) 22일 41일Piglet Weight (kg) 22 days 41 days MWI MWI 대조군 Control 7.02±1.2 10.25±1.5 7.02 ± 1.2 10.25 ± 1.5 3.22 3.22 항생제 Antibiotic 7.43±1.3 12.21±1.6 7.43 ± 1.3 12.21 ± 1.6 4.78 4.78 쇠비름속(Portulaca) 지상부(aerial parts) Portulaca aerial parts 7.12±1.1 11.33±1.4 7.12 ± 1.1 11.33 ± 1.4 4.21 4.21 쇠비름속(Portulaca) 물-에탄올(water-ethanol) 추출물 Portulaca water-ethanol extract 7.30±1.2 11.79±1.3 7.30 ± 1.2 11.79 ± 1.3 4.49 4.49

표2. 매일 섭취량의 평균 : 처리 22일과 41일 사이에 kg으로 표현된 매일의 사료 섭취 총량.Table 2. Average Daily Intake: Total daily feed intake expressed in kg between 22 and 41 days of treatment.

처리 process kg kg 대조군 Control 0.22 0.22 항생제 Antibiotic 0.37 0.37 쇠비름속(Portulaca) 지상부(aerial parts) Portulaca aerial parts 0.33 0.33 쇠비름속(Portulaca) 물-에탄올(water-ethanol) 추출물 Portulaca water-ethanol extract 0.35 0.35

표3. 다양하게 처리된 그룹에서 설사에 대한 처리 효과.Table 3. Effect of treatment on diarrhea in various treated groups.

처리 process 설사하는 동물의 % % Of diarrhea animals 대조군 Control 60 60 항생제 Antibiotic 10 10 쇠비름속(Portulaca) 지상부(aerial parts) Portulaca aerial parts 30 30 쇠비름속(Portulaca) 물-에탄올(water-ethanol) 추출물 Portulaca water-ethanol extract 20 20

표4. 41일에 채취된 대변 시료의 다른 세균 개체군(log Ufc/g)에 대한 실험 물질의 투여 효과.Table 4. Effect of administration of test substance on different bacterial populations (log Ufc / g) of fecal samples taken on day 41.

처리 process E.Coli E.Coli CBT CBT Lactobacilli Lactobacilli 항생제 Antibiotic 6.41 6.41 6.47 6.47 5.38 5.38 대조군 Control 8.05 8.05 7.55 7.55 6.93 6.93 쇠비름속(Portulaca) 지상부(aerial parts) Portulaca aerial parts 6.93 6.93 6.99 6.99 6.91 6.91 쇠비름속(Portulaca) 물-에탄올(water-ethanol) 추출물 Portulaca water-ethanol extract 6.50 6.50 6.73 6.73 6.90 6.90

Claims (7)

사료의 성장 촉진제의 제제를 위한 쇠비름속(Portulaca genus) 식물의 부분 또는 추출물의 용도.Use of a portion or extract of Portulaca genus plant for the preparation of a growth promoter in a feed. 청구항 1에 있어서, 쇠비름속(Portulaca genus)의 식물이 쇠비름(Portulaca oleracea)인 용도. The use according to claim 1, wherein the plant of the genus Portulaca genus is Portulaca oleracea . 청구항 1 또는 2에 있어서, 쇠비름속(Portulaca)의 부분이 지상부(aerial parts)인 용도.The use according to claim 1 or 2, wherein the part of Portulaca is aerial parts. 청구항 1 또는 2에 있어서, 추출물이 지상부(aerial parts) 하이드로-알코올성 추출물(hydro-alcoholic extract)인 용도.The use according to claim 1 or 2, wherein the extract is an aerial parts hydro-alcoholic extract. 혼합물 중에 적합한 담체와 쇠비름속(Portulaca genus)의 식물의 부분 또는 추출물로 구성된 수의 또는 축산 조성물.Veterinary or animal husbandry composition consisting of a suitable carrier and a portion or extract of the plant of the genus Portulaca genus in a mixture. 청구항 5에 있어서, 쇠비름(Portulaca oleracea) 지상부(aerial parts)의 지상부(aerial parts) 또는 아이드로-알코올성 추출물(extracts idro-alcholic)로 구성된 조성물.The composition of claim 5 consisting of aerial parts or extracts idro-alcholic of Portulaca oleracea aerial parts. 쇠비름속(Portulaca genus)의 식물, 특히 쇠비름(Portulaca oleracea)의 지상부(aerial parts) 또는 지상부(aerial parts) 추출물이 첨가된 사료.Feed added with extracts of aerial parts or aerial parts of the plant of the genus Portulaca genus, especially Portulaca oleracea .
KR1020077002506A 2004-08-06 2005-07-20 The use of medicinal plants and extracts thereof for the well-being of animals in veterinary medicine and zootechnics KR20070039114A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001629A ITMI20041629A1 (en) 2004-08-06 2004-08-06 USE OF MEDICINAL PLANTS AND THEIR EXTRACTS FOR ANIMAL WELFARE IN VETERINARY AND ZOOTECHNICS
ITMI2004A001629 2004-08-06

Publications (1)

Publication Number Publication Date
KR20070039114A true KR20070039114A (en) 2007-04-11

Family

ID=35149346

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077002506A KR20070039114A (en) 2004-08-06 2005-07-20 The use of medicinal plants and extracts thereof for the well-being of animals in veterinary medicine and zootechnics

Country Status (11)

Country Link
EP (1) EP1778257A1 (en)
JP (1) JP2008509098A (en)
KR (1) KR20070039114A (en)
CN (1) CN101010092A (en)
AU (1) AU2005269016A1 (en)
CA (1) CA2576103A1 (en)
IL (1) IL181161A0 (en)
IT (1) ITMI20041629A1 (en)
NO (1) NO20070661L (en)
RU (1) RU2007104345A (en)
WO (1) WO2006013001A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX354530B (en) * 2013-02-27 2018-02-19 Univ Autonoma Del Estado De Morelos Compositions comprising immp for contributing to the development, growth and improvement of the productive parameters of animals of zootechnical interest, and use of same.
CN107397805B (en) * 2017-07-07 2018-06-08 山东统盛医药科技有限公司 Improve oral hygiene, prevention and the composition and preparation method for the treatment of mouth disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1053729A (en) * 1990-02-05 1991-08-14 徐芝庭 A kind of antimicrobial and preparation method thereof
JP2583382B2 (en) * 1992-10-30 1997-02-19 中部飼料株式会社 Livestock and poultry feed containing purslane
US5688508A (en) * 1995-02-21 1997-11-18 Virginia State University Feed compositions comprising purslane leaves and methods of using thereof
CA2191923C (en) * 1996-12-03 2000-10-24 Ji-Won Yoon Portulaca oleracea and tumor cell growth
CN1081445C (en) * 1998-06-02 2002-03-27 归顺龙 Additive for feed for piglets

Also Published As

Publication number Publication date
CN101010092A (en) 2007-08-01
AU2005269016A1 (en) 2006-02-09
CA2576103A1 (en) 2006-02-09
IL181161A0 (en) 2007-07-04
NO20070661L (en) 2007-03-06
WO2006013001A1 (en) 2006-02-09
EP1778257A1 (en) 2007-05-02
RU2007104345A (en) 2008-08-10
JP2008509098A (en) 2008-03-27
ITMI20041629A1 (en) 2004-11-06

Similar Documents

Publication Publication Date Title
EP2224918B1 (en) Use of edta and its salts for prevention and treatment of bacterial intestinal diseases of pigs
JP4790129B2 (en) Use of a composition comprising carvacrol and thymol for the manufacture of a medicament for the treatment of diseases caused by treponema
KR101748368B1 (en) Fermentation feed for domestic animal comprising liquid fermented sulfuric
CN107484879A (en) Feed addictive, antibiotic-free feed and its application
CN101218930A (en) Plant source antimicrobials for raising, preparation method and application thereof
JP2021516258A (en) Use of direct feeding microorganisms in the prevention and / or treatment of E. coli-based infections in animals
KR20070039114A (en) The use of medicinal plants and extracts thereof for the well-being of animals in veterinary medicine and zootechnics
JPS5811828B2 (en) Feed and feed additives
Kyriakis et al. Evaluation of Toyocerin, a probiotic containing Bacillus toyoi spores, on health status and productivity of weaned, growing and finishing pigs
Riemensperger et al. The effect of an organic acid blend, cinnamaldehyde and a permeabilising substance on the inhibition of bacterial growth in vitro and growth performance of weaning pigs
CN109418540A (en) A kind of livestock and poultry growth promotion composition and preparation method thereof and purposes
KR20070040806A (en) The use of medicinal plants and extracts thereof with growth promoting activity in veterinary medicine and zootechnics
KR20070044442A (en) The use of paeonia and extracts thereof with growth promoting activity in veterinary medicine and zootechnics
KR20040102963A (en) Feed composition for domestic animals containing fructus chebulae
KR101273276B1 (en) Method for producing feed for livestock adding curcumin and feed for livestock produced by the same
CN107998118B (en) Preparation combining glycine and tetracycline antibiotics
KR102588133B1 (en) Ordor reducing composition
KR20040102964A (en) Feed composition for domestic animals containing a natural material
Bakun Prevention of gastrointestinal diseases in piglets at weaning using probiotics Bacillus coagylans and Bacillus megaterium
CN114747658A (en) Auxiliary feed for poultry and livestock raising and feed for poultry and livestock raising
JP2023068206A (en) Animal growth promoter and livestock feed
KR20220078267A (en) Animal feed additives comprising daphne genkwa callus or sprout
WO2021260198A1 (en) Agaricus blazei fermented grains against lawsonia intracellularis infection
CN110839772A (en) Feed additive capable of reducing nitrogen emission and improving immunity and preparation method and application thereof
KR101303925B1 (en) composition containing the charcoal for prevention and treatment of livestock diarrhea

Legal Events

Date Code Title Description
SUBM Surrender of laid-open application requested